Silent_JJ Point_NP Mutation_NP in_IN an_DT Avian_NP Retrovirus_NP RNA_NP Processing_NP Element_NP Promotes_NP c-myb-Associated_NP Short-Latency_NP Lymphomas_NP The_DT avian_JJ leukosis_NN virus_NN DeltaLR-9_NP causes_VBZ a_DT high_JJ frequency_NN of_IN B-cell_NN lymphomas_NNS within_IN weeks_NNS after_IN injection_NN into_IN 10-day-old_JJ chicken_NN embryos_NNS ._SENT These_DT lymphomas_NNS result_NN from_IN proviral_JJ integrations_NNS into_IN the_DT oncogene_NN c-myb_NN ._SENT In_IN contrast_NN ,_, LR-9_NP ,_, which_WDT lacks_VBZ the_DT 42-nucleotide_JJ gag_NN gene_NN deletion_NN of_IN DeltaLR-9_NP ,_, does_VBZ not_RB cause_VB a_DT high_JJ frequency_NN of_IN c-myb-associated_NP short-latency_NN lymphomas_NNS ._SENT Although_IN viral_JJ replication_NN rates_NNS and_CC spliced_VBD env_NP mRNA_NP levels_NNS were_VBD found_VBN to_TO be_VB similar_JJ for_IN both_DT viruses_NNS ,_, DeltaLR-9_NP exhibited_VBD an_DT increase_NN in_IN readthrough_JJ transcription_NN compared_VBN to_TO LR-9_NP ._SENT The_DT DeltaLR-9_NP deletion_NN is_VBZ located_VBN in_IN the_DT region_NN of_IN the_DT gag_NN gene_NN corresponding_JJ to_TO the_DT matrix_NN (_( MA_JJ )_) protein_NN as_IN well_RB as_RB in_IN the_DT negative_JJ regulator_NN of_IN splicing_VBG (_( NRS_JJ )_) element_NN ._SENT To_TO test_VB whether_IN disruption_NN of_IN the_DT NRS_NN or_CC of_IN the_DT MA_JJ protein_NN was_VBD responsible_JJ for_IN inducing_VBG short-latency_NN lymphomas_NNS ,_, we_PP generated_VBD viruses_NNS with_IN NRS_JJ point_NN mutations_NNS that_WDT maintained_VBD the_DT wild-type_JJ Gag_NP amino_NN acid_NN sequence_NN ._SENT One_CD of_IN the_DT mutant_JJ viruses_NNS induced_VBD an_DT even_RB higher_JJR incidence_NN than_IN DeltaLR-9_NP of_IN short-latency_NN lymphomas_NNS with_IN viral_JJ integrations_NNS into_IN c-myb_NP ._SENT Thus_RB ,_, we_PP propose_VBP that_DT disruption_NN of_IN the_DT NRS_JJ sequence_NN promotes_VBZ readthrough_JJ transcription_NN and_CC splicing_VBG to_TO the_DT downstream_JJ myb_NN gene_NN ,_, causing_VBG overexpression_NN of_IN a_DT slightly_RB truncated_VBN Myb_NP protein_NN ,_, which_WDT induces_VBZ short-latency_NN tumors_NNS ._SENT A_DT defining_VBG characteristic_NN of_IN retroviruses_NNS is_VBZ that_IN they_PP randomly_RB integrate_VB their_PP$ reverse-transcribed_JJ genome_NN into_IN the_DT genome_NN of_IN the_DT host_NN cell_NN ._SENT Selection_NN for_IN a_DT specific_JJ integration_NN site_NN can_MD occur_VB when_WRB a_DT retrovirus_NN integrates_VBZ into_IN a_DT proto-oncogene_NN ,_, resulting_VBG in_IN a_DT clonal_JJ tumor_NN ._SENT When_WRB an_DT avian_JJ leukosis_NN virus_NN (_( ALV_NP )_) is_VBZ injected_VBN into_IN 1-day-old_JJ chicks_NNS ,_, it_PP typically_RB induces_VBZ clonal_JJ B-cell_NN lymphomas_NNS exhibiting_VBG proviral_JJ DNA_NN integrated_VBN into_IN the_DT oncogene_NN c-myc_NN ._SENT These_DT B-cell_NN lymphomas_NNS result_NN from_IN the_DT deregulated_VBN expression_NN of_IN c-myc_NP and_CC take_VB several_JJ months_NNS to_TO develop_VB ._SENT However_RB ,_, if_IN an_DT ALV_NP is_VBZ injected_VBN into_IN 10-_CD to_TO 12-day-old_JJ chicken_NN embryos_NNS ,_, approximately_RB 14_CD %_NN of_IN the_DT hatched_VBN chickens_NNS develop_VBP short-latency_NN B-cell_NN lymphomas_NNS that_WDT cause_VBP death_NN within_IN weeks_NNS ._SENT Moreover_RB ,_, injection_NN of_IN chicken_NN embryos_NNS with_IN the_DT recombinant_JJ ALV_NP EU-8_NP (_( which_WDT has_VBZ a_DT 42-nucleotide_NN [_SYM nt_RB ]_SYM deletion_NN in_IN the_DT gag_NN gene_NN )_) leads_VBZ to_TO short-latency_NN B-cell_NN lymphomas_NNS in_IN 40_CD to_TO 80_CD %_NN of_IN the_DT chickens_NNS ._SENT Most_JJS of_IN these_DT short-latency_NN lymphomas_NNS contain_VBP proviral_JJ DNA_NN integrated_VBN into_IN the_DT first_JJ intron_NN of_IN c-myb_NP ._SENT Transcription_NN initiates_NNS at_IN the_DT ALV_NP promoter_NN in_IN the_DT 5_CD '_POS long_JJ terminal_NN repeat_NN (_( LTR_NP )_) and_CC reads_VBZ through_IN the_DT polyadenylation_NN sequence_NN in_IN the_DT 3_CD '_POS LTR_NP to_TO transcribe_VB the_DT downstream_JJ c-myb_NN gene_NN (_( see_VB Fig._NN )_) ._SENT Splicing_VBG then_RB occurs_VBZ from_IN the_DT 5_CD '_POS splice_NN site_NN in_IN the_DT 5_CD '_POS end_NN of_IN the_DT viral_JJ gag_NN gene_NN to_TO the_DT 3_CD '_POS splice_NN site_NN of_IN the_DT c-myb_NP second_JJ exon_NN ._SENT Translation_NN of_IN the_DT ALV-myb_NP hybrid_NN RNA_NP yields_VBZ a_DT Myb_NP protein_NN that_WDT is_VBZ truncated_VBN at_IN its_PP$ N_NP terminus_NN by_IN 20_CD amino_NN acids_NNS ._SENT Truncated_JJ Myb_NP ,_, in_IN contrast_NN to_TO full-length_JJ Myb_NP ,_, is_VBZ highly_RB oncogenic_JJ when_WRB expressed_VBN from_IN retroviral_JJ vectors_NNS introduced_VBN into_IN 12-day-old_JJ chicken_NN embryos_NNS ._SENT Further_RBR ,_, the_DT transcriptional_JJ profile_NN of_IN the_DT short-latency_NN ,_, c-myb-associated_NP tumors_NNS is_VBZ distinct_JJ from_IN that_DT of_IN c-myc-associated_NP lymphomas_NNS ._SENT The_DT higher_JJR incidence_NN of_IN short-latency_NN tumors_NNS obtained_VBN with_IN EU-8_NP than_IN with_IN other_JJ ALVs_NP has_VBZ been_VBN attributed_VBN to_TO a_DT 42-nt_JJ deletion_NN in_IN the_DT gag_NN gene_NN of_IN EU-8_NP ,_, which_WDT was_VBD derived_VBN from_IN ring-necked_JJ pheasant_NN virus_NN ._SENT This_DT same_JJ region_NN (_( nt_NN 735_CD to_TO 776_CD )_) was_VBD deleted_VBN from_IN the_DT recombinant_JJ ALV_NP LR-9_NP to_TO produce_VB DeltaLR-9_NP ._SENT When_WRB injected_VBN into_IN 10-day-old_JJ chicken_NN embryos_NNS ,_, DeltaLR-9_NP also_RB causes_VBZ mortality_NN from_IN short-latency_NN B-cell_NN lymphomas_NNS at_IN a_DT higher_JJR frequency_NN than_IN LR-9_NP ._SENT The_DT DeltaLR-9_NP genomic_JJ deletion_NN is_VBZ located_VBN within_IN the_DT gag_NN gene_NN ,_, and_CC it_PP coincides_VBZ with_IN the_DT 5_CD '_POS portion_NN of_IN a_DT viral_JJ RNA_NP element_NN termed_VBD the_DT negative_JJ regulator_NN of_IN splicing_VBG (_( NRS_NN )_) ._SENT When_WRB the_DT NRS_NN of_IN DeltaLR-9_NP was_VBD inserted_VBN into_IN the_DT intron_NN of_IN a_DT heterologous_JJ splicing_VBG reporter_NN construct_NN ,_, splicing_VBG was_VBD increased_VBN relative_JJ to_TO that_DT in_IN a_DT construct_NN containing_VBG the_DT wild-type_NN (_( WT_NP )_) LR-9_NP NRS_NP ._SENT The_DT NRS_NN has_VBZ previously_RB been_VBN characterized_VBN in_IN Rous_NP sarcoma_NN virus_NN (_( RSV_NP )_) ,_, and_CC its_PP$ sequence_NN is_VBZ 95_CD %_NN identical_JJ to_TO that_DT of_IN the_DT NRS_NN of_IN the_DT ALV_NP LR-9_NP ._SENT The_DT RSV_NP NRS_NP is_VBZ a_DT 230-nt-long_JJ cis-acting_NN element_NN ,_, which_WDT limits_VBZ both_DT RNA_NP splicing_VBG and_CC readthrough_NN transcription_NN ._SENT Both_CC of_IN these_DT processes_NNS are_VBP critical_JJ to_TO c-myb-associated_NP short-latency_NN tumorigenesis_NN ._SENT In_IN RSV_NP ,_, the_DT NRS_NN suppresses_VBZ splicing_VBG of_IN the_DT src_NN mRNA_NN but_CC not_RB of_IN env_NP mRNA_NP ._SENT The_DT NRS_NN has_VBZ two_CD regions_NNS necessary_JJ for_IN function_NN ._SENT A_DT purine-rich_JJ region_NN at_IN its_PP$ 5_CD '_POS end_NN binds_VBZ arginine/serine-rich_JJ (_( SR_NN )_) proteins_NNS and_CC hnRNP_NN H_NN ._SENT The_DT 3_CD '_POS end_NN of_IN the_DT NRS_NN contains_VBZ a_DT sequence_NN that_WDT is_VBZ similar_JJ to_TO a_DT 5_CD '_POS splice_NN site_NN and_CC binds_VBZ U1_JJ snRNP_NN ._SENT U1_JJ snRNP_NN binding_NN is_VBZ thought_VBN to_TO be_VB important_JJ for_IN NRS_JJ activity_NN ;_: mutations_NNS in_IN its_PP$ binding_JJ site_NN inhibit_VBP NRS_JJ activity_NN ,_, and_CC a_DT complementary_JJ U1_JJ snRNA_NN mutation_NN partially_RB rescues_VBZ activity_NN ._SENT The_DT deletion_NN in_IN the_DT DeltaLR-9_NP genome_NN is_VBZ also_RB within_IN the_DT region_NN of_IN gag_NN corresponding_JJ to_TO the_DT matrix_NN (_( MA_JJ )_) protein_NN ,_, thus_RB generating_VBG a_DT truncated_JJ MA_NN protein_NN (_( see_VB Fig._NN )_) ._SENT To_TO determine_VB whether_IN the_DT mutation_NN in_IN MA_NP or_CC the_DT NRS_NN was_VBD important_JJ for_IN short-latency_NN tumorigenesis_NN ,_, we_PP tested_VBD viruses_NNS with_IN point_NN mutations_NNS that_WDT code_VBP for_IN a_DT WT_NP Gag_NP protein_NN but_CC alter_VB the_DT NRS_NN ._SENT In_IN addition_NN ,_, the_DT binding_NN of_IN various_JJ splicing_VBG factors_NNS to_TO the_DT NRS_NP RNA_NP was_VBD studied_VBN with_IN the_DT NRS_JJ mutants_NNS ._SENT Finally_RB ,_, to_TO further_VB study_NN how_WRB the_DT DeltaLR-9_NP deletion_NN promotes_VBZ tumorigenesis_NN ,_, its_PP$ effects_NNS on_IN viral_JJ replication_NN ,_, env_NP mRNA_NP splicing_VBG ,_, and_CC readthrough_NN transcription_NN were_VBD examined_VBN ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Chicken_NP embryo_NN fibroblasts_NNS (_( CEFs_NP )_) were_VBD cultured_VBN in_IN medium_JJ 199_CD with_IN the_DT addition_NN of_IN 2_CD %_NN tryptose_NN phosphate_NN ,_, 1_CD %_NN calf_NN serum_NN ,_, 1_CD %_NN heat-inactivated_JJ chick_NN serum_NN ,_, and_CC 1_CD %_NN antibiotic-antimycotic_NN (_( Life_NP Technologies_NPS )_) ._SENT The_DT permuted_VBN LR-9_NP and_CC DeltaLR-9_NP ALV_NP constructs_NNS are_VBP both_CC inserted_VBN into_IN the_DT vector_NN pUC13_NN and_CC were_VBD a_DT gift_NN from_IN Bill_NP Hayward_NP ._SENT U916A_NP ,_, G919A_NP ,_, and_CC WT_NP NRS_NP ALVs_NP were_VBD constructed_VBN by_IN inserting_VBG RSV_NP fragments_NNS from_IN the_DT BspEI_NP site_NN (_( nt_NN 700_CD )_) to_TO the_DT KpnI_NP site_NN (_( nt_NN 4,995_CD )_) into_IN the_DT corresponding_JJ sites_NNS in_IN LR-9_NP ._SENT U916A_NP and_CC G919A_NP are_VBP both_CC silent_JJ mutations_NNS ,_, which_WDT were_VBD originally_RB described_VBN in_IN RSV_NP by_IN O'Sullivan_NP et_FW al._FW ._SENT Ten_CD micrograms_NNS of_IN SacI-linearized_JJ viral_JJ constructs_NNS was_VBD transfected_VBN into_IN CEFs_NP as_IN previously_RB described_VBN ._SENT Reverse_JJ transcriptase_NN assay_NN ._SENT |_SYM After_IN harvesting_NN ,_, the_DT virion-containing_NN medium_NN was_VBD assayed_VBN for_IN reverse_JJ transcriptase_NN activity_NN as_IN described_VBN by_IN Telesnitsky_NP et_FW al._FW ._SENT Quantitation_NN was_VBD performed_VBN on_IN an_DT Instant_NP Imager_NP (_( Packard_NP )_) ._SENT RNase_NP protection_NN assay_NN ._SENT |_SYM The_DT readthrough_JJ probe_NN contains_VBZ the_DT entire_JJ LR-9_NP LTR_NP and_CC flanking_VBG sequences_NNS ._SENT The_DT permuted_VBN ,_, single-LTR_NP LR-9_NP genomic_JJ plasmid_NN was_VBD digested_VBN with_IN SacI_NP (_( nt_NN 255_CD )_) and_CC HindIII_NP (_( nt_NN 7,040_CD )_) ,_, and_CC the_DT LTR_NP fragment_NN was_VBD inserted_VBN into_IN the_DT pGEM-4Z_NN cloning_VBG vector_NN (_( Stratagene_NP )_) ._SENT The_DT construct_NN was_VBD linearized_VBN with_IN BanI_NP prior_RB to_TO in_IN vitro_NN transcription_NN with_IN Sp6_NP RNA_NP polymerase_NN ._SENT Total_JJ cellular_JJ RNA_NP was_VBD harvested_VBN with_IN RNA_NP Bee_NP (_( Tel-Test_NN )_) ._SENT Readthrough_NP RNase_NP protections_NNS were_VBD carried_VBN out_RP as_RB described_VBN previously_RB by_IN using_VBG a_DT hybridization_NN temperature_NN of_IN 42C_JJ and_CC an_DT RNase_NP digestion_NN temperature_NN of_IN 37C_JJ ._SENT The_DT bands_NNS were_VBD quantified_VBN on_IN an_DT Instant_NP Imager_NP (_( Packard_NP )_) ,_, and_CC the_DT values_NNS were_VBD adjusted_VBN for_IN size_NN differences_NNS ._SENT The_DT fraction_NN of_IN readthrough_NP RNA_NP was_VBD determined_VBN relative_JJ to_TO the_DT sum_NN of_IN normally_RB polyadenylated_JJ and_CC readthrough_JJ RNA_NP bands_NNS ._SENT mRNA_NN selection_NN and_CC Northern_JJ blotting_VBG ._SENT |_SYM Polyadenylated_NP RNA_NP was_VBD selected_VBN from_IN total_JJ cellular_JJ RNA_NP by_IN binding_VBG to_TO oligo(dT)_JJ cellulose_NN ,_, and_CC the_DT selected_VBN RNA_NP was_VBD used_VBN for_IN Northern_NP blotting_VBG as_IN described_VBN by_IN Sambrook_NP and_CC Russell_NP ._SENT Viral_JJ RNA_NP was_VBD hybridized_VBN to_TO the_DT readthrough_NN (_( LTR_NP )_) probe_NN described_VBN above_IN ,_, which_WDT is_VBZ complementary_JJ to_TO both_DT spliced_VBN and_CC unspliced_VBN viral_JJ RNAs_NP ._SENT The_DT bands_NNS were_VBD quantified_VBN on_IN an_DT Instant_NP Imager_NP (_( Packard_NP )_) ._SENT Chicken_NN injection_NN and_CC tumor_NN detection_NN ._SENT |_SYM Virus_NP was_VBD collected_VBN at_IN day_NN 11_CD after_IN transfection_NN of_IN CEFs_NP ,_, and_CC 105_CD to_TO 106_CD infectious_JJ U_NP was_VBD injected_VBN into_IN the_DT chorioallantoic_JJ veins_NNS of_IN 48_CD 10-day-old_JJ chicken_NN embryos_NNS from_IN the_DT inbred_JJ SC_NP White_NP Leghorn_NP line_NN (_( Hyline_NP International_NP ,_, Dallas_NP ,_, Iowa_NP )_) ._SENT Thirty-seven_VBN of_IN the_DT injected_VBN embryos_NNS hatched_VBN ,_, and_CC 34_CD were_VBD monitored_VBN for_IN tumor_NN formation_NN ._SENT Chickens_NNS infected_VBN with_IN different_JJ viruses_NNS were_VBD kept_VBN in_IN separate_JJ cages_NNS ,_, and_CC they_PP were_VBD sacrificed_VBN when_WRB ill_JJ or_CC at_IN 10_CD weeks_NNS after_IN hatching_VBG ._SENT Each_DT chicken_NN was_VBD examined_VBN post_NN mortem_NN for_IN tumors_NNS by_IN gross_JJ examination_NN and_CC by_IN tissue_NN section_NN staining_VBG as_IN described_VBN by_IN Neiman_NP et_FW al._FW ._SENT Tissue_NN samples_NNS were_VBD collected_VBN for_IN DNA_NN extraction_NN ._SENT All_DT chicken_NN manipulations_NNS were_VBD performed_VBN without_IN knowledge_NN of_IN the_DT experimental_JJ hypothesis_NN ._SENT DNA_NP extraction_NN and_CC nested_VBD PCR_NP ._SENT |_SYM DNA_NN from_IN chicken_NN bursa_NN and_CC liver_NN tissue_NN was_VBD extracted_VBN as_IN described_VBN by_IN Sambrook_NP and_CC Russell_NP ._SENT Nested_VBN PCR_NP was_VBD carried_VBN out_RP to_TO detect_VB integrations_NNS into_IN c-myb_NP by_IN using_VBG primers_NNS specific_JJ for_IN the_DT proviral_JJ LTR_NP and_CC for_IN myb_NN exon_NN 2_CD ,_, as_RB described_VBN by_IN Neiman_NP et_FW al._FW ._SENT The_DT upstream_JJ c-myb_NP integration_NN was_VBD detected_VBN with_IN a_DT 3_CD '_POS primer_NN (_( 5'-CGGCACGGAGCGCGCTTTGCGTGCGTG-3_NP '_POS )_) upstream_JJ of_IN exon_NN 1_CD of_IN c-myb_NN in_IN conjunction_NN with_IN the_DT same_JJ LTR_NP primers_NNS ._SENT Affinity_NN selections_NNS ._SENT |_SYM The_DT viral_JJ constructs_NNS were_VBD used_VBN as_IN templates_NNS for_IN PCRs_NN with_IN a_DT T7_JJ promoter_NN (underlined)-containing_NP 5_CD '_POS primer_NN (_( 5'-TAATACGACTCACTATAGGGAGGTCCGGAGTGCATCGAGAAACC-3_NP '_POS )_) hybridizing_VBG to_TO NRS_NP nt_NNS 703_CD to_TO 727_CD and_CC a_DT 3_CD '_POS primer_NN (_( 5'-AGGGAAGGATACAAACCACTCCCCACA-3_JJ '_'' for_IN LR-9_NP ,_, DeltaLR-9_NP ,_, and_CC the_DT WT_NP ;_: 5'-AGGGAAGGATACAATCCACTCCCCACA-3_NP '_POS for_IN U916A_NP ;_: and_CC 5'-AGGGAAGGATATAAACCACTCCCCACA-3_JJ '_'' for_IN G919A_NP )_) hybridizing_VBG to_TO nt_NN 930_CD to_TO 907_CD ._SENT RNA_NP synthesis_NN ,_, linkage_NN to_TO adipic_JJ acid_JJ dihydrazide-agarose_NN beads_NNS ,_, and_CC affinity_NN selections_NNS were_VBD performed_VBN as_IN described_VBN previously_RB ._SENT Both_CC affinity-selected_JJ proteins_NNS and_CC RNAs_NP were_VBD examined_VBN ._SENT For_IN RNA_NP analysis_NN ,_, the_DT washed_JJ pellet_NN was_VBD digested_VBN with_IN 50_CD mug_NN of_IN proteinase_NN K_NP (_( Roche_NP )_) for_IN 30_CD min_NN at_IN 37C_JJ in_IN 300_CD mul_NN of_IN proteinase_NN K_NN buffer_NN ._SENT The_DT samples_NNS were_VBD then_RB boiled_VBN for_IN 30_CD s_NNS and_CC extracted_VBN with_IN phenol_NN and_CC with_IN phenol-chloroform-isoamyl_NN alcohol_NN (_( 25:24:1_CD )_) ._SENT After_IN ethanol_NN precipitation_NN ,_, the_DT pellet_NN was_VBD resuspended_VBN in_IN 20_CD mul_NN of_IN 8_CD M_NN urea_NN ,_, electrophoresed_VBN on_IN a_DT 6_CD %_NN polyacrylamide-8_JJ M_NP urea_NN gel_NN ,_, and_CC transferred_VBD to_TO a_DT Zeta-Probe_NP GT_NP blotting_VBG membrane_NN (_( Bio-Rad_NP )_) with_IN a_DT transblot_NN semidry_NN transfer_NN apparatus_NN (_( Bio-Rad_NP )_) ._SENT The_DT blot_NN was_VBD probed_VBN with_IN a_DT U1_JJ snRNA-specific_JJ probe_NN ,_, which_WDT was_VBD linearized_VBN with_IN EcoRI_NP prior_RB to_TO transcription_NN with_IN T3_NP polymerase_NN ._SENT Affinity-selected_JJ proteins_NNS were_VBD separated_VBN on_IN a_DT sodium_NN dodecyl_NN sulfate-13_NN %_NN polyacrylamide_NN gel_NN ,_, transferred_VBN ,_, and_CC probed_VBD as_RB described_VBN by_IN Sambrook_NP and_CC Russell_NP ._SENT Antibodies_NNS against_IN ASF/SF2_NP were_VBD obtained_VBN from_IN A._NP Krainer_NP ,_, and_CC antibodies_NNS against_IN hnRNP_NN H_NN were_VBD obtained_VBN from_IN I._NP Mattaj_NP ._SENT A_DT Coomassie-stained_NP gel_NN (_( GelCode_NP Blue_NP staining_VBG reagent_NN ;_: Perbio_NP )_) was_VBD used_VBN to_TO normalize_VB the_DT signals_NNS ._SENT LR-9_NP and_CC DeltaLR-9_NP exhibit_NN similar_JJ replication_NN rates_NNS and_CC env_NN mRNA_NN levels_NNS ._SENT |_SYM The_DT 42-nt_JJ deletion_NN in_IN the_DT gag_NN gene_NN of_IN DeltaLR-9_NP ALV_NP disrupts_VBZ the_DT NRS_JJ sequence_NN ,_, and_CC it_PP also_RB deletes_VBZ residues_NNS 119_CD to_TO 132_CD of_IN the_DT MA_JJ protein_NN ._SENT In_IN an_DT effort_NN to_TO determine_VB how_WRB the_DT deletion_NN in_IN DeltaLR-9_NP promotes_VBZ tumorigenesis_NN ,_, we_PP first_RB assayed_VBD its_PP$ effect_NN on_IN viral_JJ replication_NN ._SENT CEFs_NNS were_VBD infected_VBN with_IN equivalent_JJ reverse_JJ transcriptase_NN units_NNS of_IN either_DT LR-9_NP or_CC DeltaLR-9_NP virus_NN ._SENT To_TO monitor_VB growth_NN rates_NNS ,_, medium_NN was_VBD collected_VBN every_DT other_JJ day_NN starting_VBG with_IN day_NN 3_CD and_CC assayed_VBN for_IN viral_JJ reverse_JJ transcriptase_NN activity_NN ._SENT Based_VBN on_IN reverse_JJ transcriptase_NN levels_NNS ,_, the_DT replication_NN rates_NNS of_IN LR-9_NP and_CC DeltaLR-9_NP were_VBD found_VBN to_TO be_VB virtually_RB identical_JJ ._SENT Thus_RB ,_, we_PP conclude_VBP that_IN although_IN DeltaLR-9_NP has_VBZ an_DT extensive_JJ deletion_NN in_IN MA_NN and_CC in_IN the_DT NRS_JJ sequence_NN ,_, this_DT does_VBZ not_RB affect_VB the_DT replication_NN rate_NN of_IN the_DT virus_NN in_IN CEFs_NP ._SENT Next_RB ,_, we_PP wanted_VBD to_TO determine_VB whether_IN the_DT deletion_NN affected_VBD levels_NNS of_IN spliced_VBN env_NN mRNA_NN in_IN ALV_NP ._SENT In_IN RSV_NP ,_, NRS_JJ mutations_NNS increase_NN src_NN but_CC not_RB env_NP mRNA_NN levels_NNS ._SENT LR-9_NP and_CC DeltaLR-9_NP constructs_NNS were_VBD transfected_VBN into_IN CEFs_NP ,_, RNA_NP was_VBD harvested_VBN after_IN 6_CD days_NNS ,_, and_CC the_DT relative_JJ amount_NN of_IN spliced_VBN env_NN mRNA_NN was_VBD determined_VBN by_IN Northern_NP blotting_VBG with_IN an_DT LTR-specific_JJ probe_NN ._SENT In_IN this_DT assay_NN ,_, approximately_RB 35_CD %_NN of_IN LR-9_NP RNA_NP was_VBD found_VBN to_TO be_VB spliced_VBN ,_, and_CC DeltaLR-9_NP RNA_NP was_VBD spliced_VBN to_TO a_DT similar_JJ level_NN ._SENT Therefore_RB ,_, the_DT deletion_NN in_IN the_DT NRS_NN did_VBD not_RB result_VB in_IN an_DT increase_NN in_IN splicing_VBG to_TO the_DT viral_JJ env_NN gene_NN ,_, which_WDT is_VBZ consistent_JJ with_IN the_DT finding_NN that_IN replication_NN was_VBD not_RB affected_VBN by_IN the_DT deletion_NN ._SENT ALV_NP with_IN an_DT NRS_JJ deletion_NN has_VBZ increased_VBN readthrough_JJ transcription_NN ._SENT |_SYM The_DT short-latency_NN tumors_NNS induced_VBN by_IN DeltaLR-9_NP are_VBP likely_RB due_JJ to_TO overexpression_NN of_IN truncated_JJ Myb_NP ,_, which_WDT is_VBZ translated_VBN from_IN a_DT readthrough_JJ transcript_NN as_IN shown_VBN previously_RB for_IN the_DT related_JJ EU-8_NP ALV_NP ._SENT Since_IN the_DT NRS_NN has_VBZ been_VBN implicated_VBN in_IN promoting_VBG polyadenylation_NN of_IN RSV_NP transcripts_NNS ,_, we_PP next_RB wanted_VBD to_TO determine_VB whether_IN the_DT rate_NN of_IN readthrough_NN transcription_NN is_VBZ different_JJ for_IN DeltaLR-9_NP than_IN for_IN the_DT LR-9_NP virus_NN ._SENT To_TO this_DT end_NN ,_, plasmids_NNS containing_VBG LR-9_NP and_CC DeltaLR-9_NP DNAs_NP were_VBD transfected_VBN into_IN CEFs_NP ,_, and_CC total_JJ cellular_JJ RNA_NP was_VBD harvested_VBN after_IN 11_CD days_NNS ._SENT The_DT levels_NNS of_IN readthrough_JJ transcription_NN were_VBD compared_VBN to_TO those_DT of_IN correctly_RB terminated_VBN transcripts_NNS by_IN RNase_NP protection_NN with_IN a_DT readthrough_JJ probe_NN that_WDT was_VBD complementary_JJ to_TO the_DT LR-9_NP LTR_NP and_CC flanking_VBG sequences_NNS ._SENT In_IN these_DT experiments_NNS ,_, it_PP was_VBD not_RB important_JJ where_WRB the_DT virus_NN was_VBD integrated_VBN ,_, because_IN only_JJ readthrough_NN into_IN viral_JJ sequences_NNS was_VBD assayed_VBN ._SENT LR-9_NP was_VBD determined_VBN to_TO have_VB an_DT average_NN of_IN 10_CD %_NN readthrough_NN transcripts_NNS (_( relative_JJ to_TO the_DT total_JJ amount_NN of_IN readthrough_NN and_CC normally_RB terminated_VBD polyadenylated_JJ RNA_NP )_) ,_, and_CC DeltaLR-9_NP had_VBD a_DT 60_CD %_NN higher_JJR amount_NN of_IN readthrough_NN (_( P_NN <_SYM 0.005_CD )_) ._SENT We_PP conclude_VBP that_IN one_CD of_IN the_DT factors_NNS that_WDT causes_VBZ DeltaLR-9_NP to_TO induce_VB short-latency_NN lymphomas_NNS is_VBZ that_IN it_PP exhibits_VBZ a_DT higher_JJR level_NN of_IN readthrough_JJ transcription_NN into_IN downstream_JJ cellular_JJ genes_NNS than_IN does_VBZ LR-9_NP ._SENT In_IN addition_NN ,_, it_PP was_VBD previously_RB shown_VBN that_IN the_DT NRS_NN of_IN DeltaLR-9_NP promotes_VBZ splicing_VBG to_TO a_DT downstream_JJ reporter_NN gene_NN ._SENT Is_VBZ the_DT deletion_NN in_IN the_DT MA_JJ protein_NN or_CC the_DT NRS_JJ sequence_NN of_IN DeltaLR-9_NP responsible_JJ for_IN the_DT increase_NN in_IN short-latency_NN lymphomas_NNS ?_SENT |_SYM The_DT short-latency_NN tumors_NNS induced_VBN by_IN DeltaLR-9_NP may_MD be_VB due_JJ to_TO either_CC an_DT altered_JJ MA_NN protein_NN or_CC the_DT disruption_NN of_IN the_DT overlapping_JJ NRS_JJ sequence_NN (_( or_CC both_DT )_) ._SENT To_TO distinguish_VB between_IN these_DT possibilities_NNS ,_, we_PP generated_VBD point_NN mutations_NNS that_WDT changed_VBD the_DT NRS_JJ sequence_NN but_CC did_VBD not_RB affect_VB the_DT amino_NN acid_NN sequence_NN of_IN the_DT MA_JJ protein_NN ._SENT We_PP constructed_VBD two_CD viruses_NNS ,_, U916A_NP and_CC G919A_NP ,_, each_DT having_VBG a_DT single_JJ NRS_JJ point_NN mutation_NN but_CC lacking_VBG the_DT 42-nt_JJ deletion_NN of_IN DeltaLR-9_NP ._SENT U1_JJ snRNP_NN binding_NN has_VBZ been_VBN shown_VBN previously_RB to_TO be_VB important_JJ for_IN NRS_JJ function_NN ,_, and_CC both_DT of_IN these_DT mutations_NNS were_VBD predicted_VBN to_TO disrupt_VB the_DT U1_JJ snRNP_NN binding_VBG consensus_NN sequence_NN ._SENT Nevertheless_RB ,_, only_RB one_CD of_IN these_DT point_NN mutations_NNS ,_, G919A_NP ,_, led_VBD to_TO an_DT increase_NN in_IN readthrough_JJ transcription_NN and_CC splicing_VBG to_TO src_NN in_IN RSV_NP ._SENT Since_IN both_DT readthrough_NN and_CC splicing_VBG are_VBP thought_VBN to_TO be_VB important_JJ for_IN the_DT generation_NN of_IN truncated_JJ Myb_NP ,_, we_PP predicted_VBD that_IN the_DT U916A_NP mutant_JJ virus_NN would_MD behave_VB like_IN WT_NP virus_NN ._SENT The_DT viruses_NNS with_IN point_NN mutations_NNS ,_, U916A_NP and_CC G919A_NP ,_, and_CC the_DT WT_NP NRS_NP control_NN virus_NN were_VBD constructed_VBN by_IN placing_VBG the_DT corresponding_JJ RSV_NP fragments_NNS (_( nt_NN 700_CD to_TO 4,995_CD )_) ,_, described_VBD previously_RB ,_, into_IN the_DT LR-9_NP background_NN ._SENT The_DT replication_NN abilities_NNS of_IN the_DT constructs_NNS were_VBD confirmed_VBN in_IN CEFs_NNS through_IN reverse_JJ transcriptase_NN assays_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO determine_VB the_DT tumorigenicity_NN of_IN the_DT viral_JJ constructs_NNS ,_, we_PP injected_VBD 12_CD 10-day-old_JJ chicken_NN embryos_NNS with_IN one_CD of_IN the_DT following_VBG four_CD test_NN viruses_NNS :_: the_DT viruses_NNS with_IN point_NN mutations_NNS ,_, U916A_NP and_CC G919A_NP ,_, the_DT WT_NP NRS_NP (_( negative_JJ control_NN )_) virus_NN ,_, and_CC DeltaLR-9_NP (_( positive_JJ control_NN )_) ._SENT Out_RB of_IN the_DT total_NN of_IN 48_CD injected_VBD chicken_NN embryos_NNS ,_, 37_CD chicks_NNS hatched_VBN and_CC 34_CD were_VBD monitored_VBN for_IN deaths_NNS and_CC the_DT development_NN of_IN tumors_NNS for_IN 10_CD weeks_NNS after_IN hatching_VBG ._SENT Surviving_VBG chickens_NNS were_VBD sacrificed_VBN at_IN week_NN 10_CD ,_, and_CC all_DT chickens_NNS were_VBD examined_VBN for_IN tumors_NNS at_IN the_DT time_NN of_IN their_PP$ death_NN ._SENT We_PP asked_VBD whether_IN short-latency_NN lymphomas_NNS (_( causing_VBG death_NN within_IN 10_CD weeks_NNS after_IN hatching_VBG )_) would_MD arise_VB at_IN the_DT same_JJ frequency_NN with_IN the_DT viruses_NNS carrying_VBG NRS_JJ point_NN mutations_NNS as_RB with_IN the_DT positive_JJ control_NN virus_NN ,_, DeltaLR-9_NP ._SENT The_DT percentages_NNS of_IN chickens_NNS that_WDT died_VBD ,_, or_CC were_VBD sacrificed_VBN for_IN humane_JJ reasons_NNS ,_, before_RB 10_CD weeks_NNS after_IN hatching_VBG (_( defined_VBN as_IN the_DT short-latency_NN period_NN )_) and_CC that_IN exhibited_VBN lymphomas_NNS are_VBP plotted_VBN in_IN Fig._NN ._SENT Lymphomas_NNS were_VBD detected_VBN both_CC by_IN gross_JJ examination_NN and_CC by_IN histological_JJ analysis_NN ._SENT The_DT group_NN infected_VBN with_IN the_DT positive_JJ control_NN ,_, DeltaLR-9_NP ,_, showed_VBD a_DT rate_NN of_IN mortality_NN from_IN lymphomas_NNS of_IN 44_CD %_NN (_( four_CD of_IN nine_CD birds_NNS )_) ,_, which_WDT is_VBZ similar_JJ to_TO the_DT 54_CD %_NN that_DT Smith_NP et_FW al._FW observed_JJ by_IN week_NN 10_CD with_IN the_DT same_JJ viral_JJ construct_NN ._SENT Remarkably_RB ,_, the_DT G919A_NP viral_JJ construct_NN ,_, which_WDT has_VBZ only_RB a_DT single_JJ point_NN mutation_NN compared_VBN to_TO the_DT WT_NP ,_, induced_VBD a_DT 75_CD %_NN (_( six_CD of_IN eight_CD birds_NNS )_) rate_NN of_IN mortality_NN from_IN short-latency_NN lymphomas_NNS in_IN this_DT same_JJ time_NN period_NN ._SENT Moreover_RB ,_, one_CD of_IN these_DT G919A-induced_NP lymphomas_NNS was_VBD extraordinarily_RB large_JJ ;_: the_DT metastatic_JJ tumor_NN filled_VBD the_DT full_JJ length_NN of_IN the_DT chicken_NN 's_POS body_NN cavity_NN ._SENT The_DT group_NN receiving_VBG the_DT negative_JJ control_NN WT_NP virus_NN ,_, which_WDT has_VBZ a_DT WT_NP NRS_NN sequence_NN ,_, exhibited_VBD a_DT 10_CD %_NN (_( 1_CD of_IN 10_CD birds_NNS )_) rate_NN of_IN mortality_NN from_IN lymphomas_NNS ,_, similar_JJ to_TO the_DT rate_NN that_WDT was_VBD found_VBN by_IN Smith_NP et_FW al._FW for_IN LR-9_NP ._SENT Those_DT infected_JJ with_IN the_DT other_JJ silent_JJ mutant_NN ,_, U916A_NP ,_, showed_VBD only_RB a_DT 14_CD %_NN (_( one_CD of_IN seven_CD birds_NNS )_) mortality_NN rate_NN that_WDT was_VBD close_JJ to_TO that_DT for_IN the_DT negative_JJ control_NN ._SENT U916A_NP did_VBD not_RB induce_VB any_DT short-latency_NN tumors_NNS observable_JJ by_IN gross_JJ examination_NN ,_, but_CC one_CD bird_NN ,_, which_WDT died_VBD 7_CD weeks_NNS after_IN hatching_VBG ,_, exhibited_VBD a_DT large_JJ number_NN of_IN neoplastic_JJ follicles_NNS (_( 20_CD %_NN of_IN the_DT total_NN )_) in_IN the_DT bursa_NN (_( for_IN a_DT detailed_JJ discussion_NN of_IN neoplastic_JJ follicles_NNS ,_, see_VBP reference_NN )_) ._SENT Additional_JJ symptoms_NNS exhibited_VBN by_IN most_JJS chickens_NNS that_WDT died_VBD from_IN short-latency_NN lymphomas_NNS included_VBD anemia_NN ,_, ataxia_NN ,_, cachexia_NN ,_, and_CC hepatomegaly_RB ._SENT Short-latency_NN lymphomas_NNS are_VBP associated_VBN with_IN integrations_NNS into_IN c-myb_NP ._SENT |_SYM We_PP next_RB wanted_VBD to_TO determine_VB the_DT integration_NN sites_NNS of_IN proviruses_NNS in_IN chickens_NNS that_WDT died_VBD from_IN short-latency_NN lymphomas_NNS ._SENT Proviral_JJ integrations_NNS into_IN the_DT c-myb_NP gene_NN were_VBD seen_VBN previously_RB in_IN tumors_NNS induced_VBN by_IN the_DT EU-8_NP ALV_NP ,_, which_WDT has_VBZ an_DT NRS_JJ deletion_NN identical_JJ to_TO that_DT of_IN DeltaLR-9_NP ._SENT DNA_NP was_VBD extracted_VBN from_IN both_DT bursa_NN and_CC liver_NN tissues_NNS of_IN the_DT chickens_NNS ._SENT Proviral_JJ integration_NN into_IN c-myb_NP was_VBD assayed_VBN by_IN nested_VBN PCR_NP by_IN using_VBG primers_NNS in_IN the_DT viral_JJ LTR_NP and_CC either_RB in_IN c-myb_NP exon_NN 2_CD or_CC upstream_RB of_IN c-myb_NP exon_NN 1_CD (_( primer_NN location_NN not_RB shown_VBN )_) ._SENT A_DT PCR_NP product_NN indicated_VBD that_IN there_EX was_VBD an_DT integration_NN into_IN c-myb_NP in_IN the_DT same_JJ transcriptional_JJ orientation_NN as_IN c-myb_NP ._SENT All_DT of_IN the_DT chickens_NNS that_WDT died_VBD with_IN lymphomas_NNS during_IN the_DT 10-week_JJ period_NN after_IN hatching_VBG (_( defined_VBN here_RB as_IN short-latency_NN lymphomas_NNS )_) did_VBD indeed_RB show_VB proviral_JJ integrations_NNS into_IN c-myb_NP ._SENT In_IN addition_NN ,_, a_DT number_NN of_IN birds_NNS sacrificed_VBN at_IN week_NN 10_CD were_VBD also_RB found_VBN to_TO have_VB lymphomas_NNS ._SENT We_PP asked_VBD whether_IN the_DT chickens_NNS that_WDT developed_VBD lymphomas_NNS but_CC did_VBD not_RB die_VB by_IN week_NN 10_CD also_RB had_VBD proviral_JJ integrations_NNS into_IN the_DT c-myb_NP gene_NN ._SENT The_DT percentage_NN of_IN chickens_NNS that_WDT developed_VBD these_DT lymphomas_NNS is_VBZ shown_VBN in_IN Fig._NN ._SENT DeltaLR-9_NP induced_VBD lethal_JJ lymphomas_NNS in_IN 44_CD %_NN (_( four_CD of_IN nine_CD )_) and_CC nonlethal_NN lymphomas_NNS in_IN 33_CD %_NN (_( three_CD of_IN nine_CD )_) of_IN the_DT infected_JJ chickens_NNS ;_: all_RB of_IN these_DT birds_NNS exhibited_VBD proviral_JJ integrations_NNS into_IN c-myb_NP ._SENT Nonlethal_NN lymphomas_NNS were_VBD induced_VBN by_IN U916A_NP in_IN 28_CD %_NN (_( two_CD of_IN seven_CD )_) of_IN the_DT chickens_NNS ,_, but_CC only_RB one_CD of_IN these_DT chickens_NNS had_VBD a_DT c-myb_NP integration_NN ._SENT Of_IN the_DT chickens_NNS infected_VBN with_IN the_DT G919A_NP ALV_NP mutant_NN ,_, 75_CD %_NN (_( six_CD of_IN eight_CD )_) developed_JJ lymphomas_NNS and_CC died_VBD before_IN week_NN 10_CD ;_: all_DT of_IN these_DT short-latency_NN lymphomas_NNS were_VBD associated_VBN with_IN proviral_JJ integrations_NNS into_IN c-myb_NP ._SENT No_DT nonlethal_NN lymphomas_NNS were_VBD observed_VBN in_IN the_DT remaining_VBG two_CD birds_NNS infected_VBN with_IN G919A_NP ._SENT Finally_RB ,_, the_DT negative_JJ control_NN (_( WT_NP )_) induced_VBD nonlethal_NN lymphomas_NNS in_IN 50_CD %_NN (_( 5_CD of_IN 10_CD )_) of_IN the_DT chickens_NNS ._SENT Interestingly_RB ,_, only_RB one_CD of_IN these_DT chickens_NNS had_VBD a_DT proviral_JJ integration_NN into_IN c-myb_NP ._SENT The_DT non-myb-associated_JJ ,_, nonlethal_NN (_( at_IN week_NN 10_CD )_) lymphomas_NNS induced_VBN by_IN either_CC the_DT WT_NP NRS_NN virus_NN or_CC the_DT U916A_NP mutant_NN are_VBP likely_JJ to_TO have_VB proviral_JJ integrations_NNS into_IN other_JJ proto-oncogenes_NNS ._SENT There_EX were_VBD no_DT morphological_JJ differences_NNS between_IN the_DT short-latency_NN lymphomas_NNS and_CC the_DT nonlethal_NN lymphomas_NNS (_( by_IN 10_CD weeks_NNS )_) observable_JJ by_IN either_DT gross_JJ examination_NN or_CC histological_JJ staining_VBG (_( data_NNS not_RB shown_VBN )_) ._SENT Finally_RB ,_, by_IN this_DT PCR_NP assay_NN ,_, c-myb_NP integrations_NNS into_IN DNA_NN from_IN both_CC the_DT bursa_NN and_CC liver_NN were_VBD observed_VBN in_IN the_DT absence_NN of_IN obvious_JJ tumor_NN formation_NN in_IN six_CD chickens_NNS (_( three_CD infected_VBN with_IN U916A_NP ,_, one_CD with_IN G919A_NP ,_, and_CC two_CD with_IN WT_NP )_) but_CC not_RB in_IN a_DT control_NN uninfected_JJ chicken_NN ._SENT Even_RB though_IN observable_JJ tumors_NNS did_VBD not_RB develop_VB in_IN these_DT chickens_NNS ,_, there_EX appears_VBZ to_TO have_VB been_VBN some_DT selection_NN for_IN cells_NNS with_IN proviral_JJ integration_NN into_IN c-myb_NP ._SENT Integration_NN sites_NNS cluster_NN within_IN 900_CD nt_NNS upstream_RB of_IN c-myb_NP exon_NN 2_CD ._SENT |_SYM To_TO determine_VB whether_IN specific_JJ integration_NN sites_NNS correlated_VBN with_IN the_DT induction_NN of_IN short-latency_NN lymphomas_NNS ,_, we_PP mapped_VBD the_DT approximate_JJ sites_NNS of_IN proviral_JJ insertion_NN into_IN c-myb_NP based_VBN on_IN the_DT sizes_NNS of_IN the_DT PCR_NP products_NNS ._SENT Strikingly_RB ,_, most_JJS of_IN the_DT integration_NN sites_NNS clustered_VBN within_IN 900_CD nt_NNS upstream_RB of_IN the_DT start_NN of_IN c-myb_NP exon_NN 2_CD ._SENT In_IN addition_NN ,_, one_CD integration_NN site_NN was_VBD found_VBN upstream_RB of_IN c-myb_NP exon_NN 1_CD in_IN the_DT bursa_NN and_CC the_DT liver_NN of_IN a_DT G919A-infected_JJ chicken_NN (_( by_IN using_VBG an_DT alternate_JJ upstream_JJ myb_NN primer_NN )_) ._SENT There_EX was_VBD no_DT apparent_JJ difference_NN between_IN the_DT integration_NN sites_NNS found_VBN in_IN lymphomas_NNS induced_VBN by_IN the_DT different_JJ viral_JJ constructs_NNS ._SENT In_IN addition_NN ,_, short-latency_NN lymphomas_NNS and_CC lymphomas_NNS that_WDT did_VBD not_RB lead_VB to_TO death_NN in_IN the_DT time_NN course_NN of_IN the_DT experiment_NN exhibited_VBD similar_JJ proviral_JJ integration_NN sites_NNS ._SENT Most_JJS chickens_NNS that_WDT had_VBD an_DT integration_NN into_IN c-myb_NP intron_NP 1_CD had_VBD only_RB one_CD such_JJ integration_NN ;_: however_RB ,_, multiple_JJ c-myb_NP integrations_NNS (_( two_CD or_CC three_CD )_) were_VBD seen_VBN in_IN six_CD chickens_NNS ._SENT Effects_NNS of_IN mutations_NNS on_IN the_DT binding_NN of_IN factors_NNS to_TO the_DT NRS_NN ._SENT |_SYM The_DT NRS_NN was_VBD shown_VBN to_TO be_VB important_JJ in_IN preventing_VBG tumorigenesis_NN since_IN the_DT virus_NN with_IN the_DT NRS_JJ point_NN mutation_NN G919A_NP caused_VBD a_DT high_JJ frequency_NN of_IN short-latency_NN lymphomas_NNS ,_, even_RB though_IN it_PP encoded_VBD a_DT WT_NP MA_NN protein_NN ._SENT Since_IN the_DT U916A_NP mutant_NN did_VBD not_RB cause_VB a_DT high_JJ frequency_NN of_IN short-latency_NN lymphomas_NNS ,_, we_PP wanted_VBD to_TO determine_VB whether_IN the_DT mutant_JJ RNAs_NP differed_VBD in_IN the_DT binding_NN of_IN U1_JJ snRNP_NN or_CC other_JJ factors_NNS ._SENT Affinity_NN selection_NN experiments_NNS were_VBD carried_VBN out_RP with_IN NRS_NP RNAs_NP from_IN LR-9_NP ,_, DeltaLR-9_NP ,_, U916A_NP ,_, G919A_NP ,_, and_CC WT_NP (_( RSV_NP )_) viral_JJ constructs_NNS ._SENT The_DT NRS_NP RNAs_NP (_( RSV_NP nt_VBD 703_CD to_TO 930_CD )_) were_VBD transcribed_VBN in_IN vitro_NN and_CC covalently_RB linked_VBN to_TO agarose_JJ beads_NNS ._SENT After_IN incubation_NN with_IN HeLa_NP nuclear_JJ extract_NN ,_, the_DT levels_NNS of_IN binding_VBG of_IN hnRNP_NP H_NP and_CC ASF/SF2_NP proteins_NNS and_CC U1_JJ snRNA_NN were_VBD determined_VBN by_IN Western_NP and_CC Northern_NP blot_NN analysis_NN ,_, respectively_RB ._SENT These_DT particular_JJ factors_NNS were_VBD selected_VBN because_IN they_PP have_VBP been_VBN shown_VBN previously_RB to_TO have_VB a_DT functional_JJ interaction_NN with_IN the_DT RSV_NP NRS_NN ._SENT The_DT levels_NNS of_IN binding_VBG of_IN both_DT hnRNP_NP H_NP and_CC ASF/SF2_NP were_VBD found_VBN to_TO be_VB substantially_RB reduced_VBN for_IN DeltaLR-9_NP RNA_NP relative_JJ to_TO those_DT for_IN LR-9_NP RNA_NP and_CC RNAs_NP of_IN all_PDT the_DT other_JJ constructs_NNS ._SENT This_DT suggests_VBZ that_IN the_DT primary_JJ binding_JJ sites_NNS for_IN ASF/SF2_NP and_CC hnRNP_NP H_NP in_IN the_DT NRS_NN are_VBP in_IN the_DT region_NN spanning_VBG nt_NN 735_CD to_TO 776_CD ._SENT However_RB ,_, DeltaLR-9_NP RNA_NP did_VBD show_VB a_DT low_JJ level_NN of_IN binding_VBG of_IN both_DT ASF/SF2_NP and_CC hnRNP_NP H_NP ,_, suggesting_VBG that_IN there_EX may_MD be_VB additional_JJ binding_JJ sites_NNS outside_JJ of_IN the_DT deleted_VBN region_NN ._SENT McNally_NP and_CC McNally_NP reported_VBD that_IN ASF/SF2_NP binding_NN was_VBD greatly_RB decreased_VBN by_IN the_DT deletion_NN of_IN nt_NN 715_CD to_TO 748_CD of_IN the_DT RSV_NP NRS_NP ,_, suggesting_VBG that_IN there_EX may_MD be_VB additional_JJ binding_JJ sites_NNS upstream_RB of_IN the_DT deletion_NN in_IN DeltaLR-9_NP ,_, as_RB shown_VBN in_IN Fig._NN ._SENT Surprisingly_RB ,_, levels_NNS of_IN U1_JJ snRNA_NN binding_NN were_VBD found_VBN to_TO be_VB identical_JJ for_IN LR-9_NP and_CC DeltaLR-9_NP RNAs_NP in_IN this_DT in_IN vitro_NN assay_NN ._SENT Thus_RB ,_, ASF/SF2_JJ binding_NN to_TO nt_NN 735_CD to_TO 776_CD of_IN the_DT NRS_NN does_VBZ not_RB seem_VB to_TO be_VB necessary_JJ for_IN U1_JJ snRNP_NN recruitment_NN to_TO the_DT 3_CD '_POS end_NN of_IN the_DT NRS_NN ._SENT Furthermore_RB ,_, the_DT two_CD viruses_NNS with_IN NRS_JJ point_NN mutations_NNS ,_, U916A_NP and_CC G919A_NP ,_, both_CC showed_VBD sharply_RB diminished_VBN U1_JJ snRNA_NN binding_NN ._SENT Thus_RB ,_, the_DT difference_NN in_IN short-latency_NN tumor_NN induction_NN by_IN the_DT U916A_NP and_CC G919A_NP viruses_NNS could_MD not_RB be_VB explained_VBN by_IN differential_JJ U1_JJ snRNP_NN binding_VBG in_IN this_DT assay_NN ._SENT In_IN summary_NN ,_, the_DT 5_CD '_POS region_NN of_IN the_DT NRS_JJ (_( specifically_RB nt_VBG 735_CD to_TO 776_CD )_) binds_VBZ hnRNP_NP H_NP and_CC ASF/SF2_NP ,_, and_CC the_DT 3_CD '_POS region_NN of_IN the_DT NRS_NN binds_VBZ U1_JJ snRNP_NN ._SENT We_PP were_VBD unable_JJ to_TO differentiate_VB between_IN U916A_NP and_CC G919A_NP on_IN the_DT basis_NN of_IN the_DT binding_NN of_IN these_DT factors_NNS ;_: however_RB ,_, there_EX may_MD be_VB other_JJ proteins_NNS that_WDT bind_VBP differentially_RB to_TO these_DT two_CD mutants_NNS ._SENT In_IN this_DT study_NN ,_, LR-9_NP and_CC DeltaLR-9_NP ALVs_NP ,_, which_WDT differ_VBP only_RB by_IN a_DT 42-nt_JJ deletion_NN in_IN the_DT gag_NN gene_NN ,_, were_VBD found_VBN to_TO have_VB the_DT same_JJ replication_NN rates_NNS and_CC the_DT same_JJ amounts_NNS of_IN spliced_VBN env_NN mRNA_NN ._SENT However_RB ,_, readthrough_JJ transcription_NN was_VBD found_VBN to_TO be_VB higher_JJR with_IN DeltaLR-9_NP than_IN with_IN LR-9_NP ._SENT In_IN addition_NN ,_, the_DT DeltaLR-9_NP NRS_NP was_VBD shown_VBN previously_RB to_TO increase_VB splicing_VBG to_TO a_DT downstream_JJ reporter_NN gene_NN ._SENT When_WRB injected_VBN into_IN 10-day-old_JJ chicken_NN embryos_NNS ,_, the_DT G919A_NP ,_, but_CC not_RB the_DT U916A_NP ,_, NRS_JJ point-mutation_NN virus_NN showed_VBD an_DT even_RB higher_JJR rate_NN of_IN tumor_NN formation_NN than_IN DeltaLR-9_NP ._SENT Thus_RB ,_, the_DT deletion_NN in_IN the_DT viral_JJ MA_NN protein_NN was_VBD not_RB found_VBN to_TO be_VB necessary_JJ for_IN short-latency_NN lymphoma_NN formation_NN ._SENT We_PP conclude_VBP that_IN the_DT high_JJ frequency_NN of_IN short-latency_NN tumors_NNS with_IN proviral_JJ integrations_NNS into_IN c-myb_NP is_VBZ associated_VBN with_IN inactivation_NN of_IN the_DT NRS_NN ,_, implicating_VBG RNA_NP processing_NN as_IN the_DT prime_JJ determinant_NN of_IN short-latency_NN tumorigenesis_NN in_IN this_DT system_NN ._SENT The_DT NRS_NN is_VBZ not_RB necessary_JJ for_IN viral_JJ replication_NN in_IN CEFs_NP ._SENT |_SYM The_DT replication_NN rates_NNS of_IN LR-9_NP and_CC DeltaLR-9_NP were_VBD found_VBN to_TO be_VB identical_JJ in_IN CEFs_NP ._SENT Thus_RB ,_, a_DT 42-nt_JJ deletion_NN in_IN the_DT 5_CD '_POS portion_NN of_IN the_DT NRS_NN did_VBD not_RB impair_VB replication_NN rates_NNS ._SENT Similarly_RB ,_, O'Sullivan_NP et_FW al._FW did_VBD not_RB find_VB substantial_JJ replication_NN impairment_NN in_IN RSV_NP mutants_NNS bearing_VBG single_JJ point_NN mutations_NNS in_IN the_DT 3_CD '_POS portion_NN of_IN the_DT NRS_NN ._SENT However_RB ,_, some_DT replication_NN impairment_NN was_VBD observed_VBN at_IN early_JJ time_NN points_NNS with_IN RSV_NP containing_VBG three_CD scattered_JJ point_NN mutations_NNS in_IN the_DT 3_CD '_POS region_NN of_IN the_DT NRS_NN ._SENT The_DT DeltaLR-9_NP deletion_NN is_VBZ also_RB in_IN the_DT MA_JJ protein-encoding_NN region_NN (_( corresponding_JJ to_TO residues_NNS 119_CD to_TO 132_CD )_) of_IN the_DT virus_NN ._SENT MA_NN is_VBZ the_DT adapter_NN protein_NN that_WDT anchors_VBZ the_DT viral_JJ core_NN to_TO the_DT cell_NN 's_POS Env-studded_JJ lipid_NN bilayer_NN so_IN that_DT new_JJ virions_NNS can_MD bud_VB out_RP of_IN the_DT cell_NN ._SENT Consistent_JJ with_IN our_PP$ findings_NNS ,_, Nelle_NP and_CC Wills_NP found_VBD that_IN the_DT entire_JJ C-terminal_JJ half_NN of_IN RSV_NP MA_NP (_( residues_NNS 87_CD to_TO 155_CD )_) is_VBZ dispensable_JJ for_IN budding_VBG and_CC infectivity_NN in_IN QT6_NP cells_NNS ._SENT Thus_RB ,_, this_DT region_NN of_IN the_DT virus_NN does_VBZ not_RB seem_VB to_TO be_VB necessary_JJ for_IN replication_NN ,_, even_RB though_IN removing_VBG it_PP deletes_VBZ portions_NNS of_IN the_DT MA_JJ protein_NN and_CC of_IN the_DT NRS_NN ._SENT Furthermore_RB ,_, the_DT level_NN of_IN splicing_VBG to_TO the_DT viral_JJ gene_NN env_NN was_VBD not_RB affected_VBN by_IN the_DT 42-nt_JJ deletion_NN in_IN DeltaLR-9_NP or_CC by_IN NRS_JJ point_NN mutations_NNS in_IN RSV_NP ._SENT The_DT NRS_NN promotes_VBZ polyadenylation_NN ._SENT |_SYM Expression_NN of_IN truncated_JJ Myb_NP to_TO induce_VB short-latency_NN lymphomas_NNS necessitates_VBZ readthrough_JJ transcription_NN followed_VBN by_IN splicing_VBG to_TO c-myb_NP ._SENT Readthrough_NP transcription_NN was_VBD found_VBN to_TO be_VB increased_VBN in_IN the_DT NRS_JJ mutant_JJ DeltaLR-9_NN in_IN this_DT study_NN ._SENT The_DT level_NN of_IN readthrough_JJ transcription_NN was_VBD determined_VBN to_TO be_VB similar10_JJ %_NN for_IN LR-9_NP ._SENT The_DT deletion_NN in_IN the_DT NRS_NN increased_VBD the_DT level_NN of_IN readthrough_NN by_IN 60_CD %_NN ._SENT The_DT NRS_NN was_VBD previously_RB implicated_VBN by_IN Miller_NP and_CC Stoltzfus_NP in_IN the_DT regulation_NN of_IN polyadenylation_NN of_IN RSV_NP RNA_NP ._SENT In_IN that_DT study_NN ,_, large_JJ deletions_NNS ,_, which_WDT overlapped_VBD in_IN a_DT 606-nt_JJ region_NN including_VBG the_DT NRS_NN ,_, led_VBN to_TO readthrough_NN of_IN 50_CD %_NN of_IN the_DT viral_JJ RNA_NP ._SENT More_RBR recently_RB ,_, Fogel_NP et_FW al._FW and_CC O'Sullivan_NP et_FW al._FW found_VBD that_IN more-limited_JJ mutations_NNS in_IN the_DT NRS_NN also_RB increased_VBD the_DT level_NN of_IN readthrough_JJ transcription_NN in_IN RSV_NP ._SENT Thus_RB ,_, one_CD of_IN the_DT functions_NNS of_IN the_DT WT_NP NRS_NP appears_VBZ to_TO be_VB the_DT promotion_NN of_IN efficient_JJ polyadenylation_NN at_IN a_DT site_NN 6.5_CD kb_NN downstream_JJ ._SENT Since_IN polyadenylation_NN can_MD be_VB promoted_VBN by_IN an_DT upstream_JJ 3_CD '_POS splice_NN site_NN and_CC the_DT ALV_NP env_NP 3_CD '_POS splice_NN site_NN is_VBZ weak_JJ ,_, the_DT NRS_NN may_MD promote_VB polyadenylation_NN either_CC directly_RB or_CC indirectly_RB through_IN interaction_NN with_IN the_DT 3_CD '_POS splice_NN site_NN ._SENT The_DT NRS_JJ regulation_NN of_IN polyadenylation_NN may_MD be_VB modulated_VBN through_IN hnRNP_NN H_NN or_CC SR_NN protein_NN binding_NN ._SENT This_DT study_NN reports_VBZ that_IN DeltaLR-9_NP ,_, which_WDT exhibited_VBD reduced_VBN hnRNP_NN H_NN and_CC SR_NN protein_NN binding_NN ,_, showed_VBD an_DT increase_NN in_IN readthrough_JJ transcription_NN and_CC a_DT concomitant_JJ increase_NN in_IN short-latency_NN tumor_NN formation_NN ._SENT There_EX are_VBP two_CD GGGA_NP sequences_NNS in_IN the_DT deleted_VBN region_NN (_( nt_NN 735_CD to_TO 776_CD )_) ;_: this_DT sequence_NN has_VBZ been_VBN shown_VBN to_TO be_VB a_DT binding_JJ site_NN for_IN hnRNP_NN H_NN ._SENT Further_RBR ,_, a_DT member_NN of_IN the_DT hnRNP_JJ H_NN family_NN ,_, DSEF-1_NP ,_, has_VBZ been_VBN reported_VBN to_TO bind_VB to_TO a_DT G-rich_NP region_NN downstream_RB of_IN the_DT simian_JJ virus_NN 40_CD poly(A)_NN sequence_NN ,_, where_WRB it_PP helps_VBZ to_TO recruit_VB cleavage-stimulating_VBG factor_NN to_TO aid_NN both_CC in_IN cleavage_NN and_CC in_IN polyadenylation_NN ._SENT hnRNP_NP H_NP may_MD perform_VB a_DT similar_JJ function_NN for_IN the_DT NRS_NN ._SENT Binding_VBG of_IN hnRNP_NN H_NN to_TO an_DT RSV_NP NRS_NN fragment_NN containing_VBG nt_NN 740_CD to_TO 770_CD was_VBD previously_RB reported_VBN by_IN Fogel_NP and_CC McNally_NP ._SENT However_RB ,_, an_DT RSV_NP mutant_NN bearing_VBG extensive_JJ point_NN mutations_NNS in_IN this_DT region_NN failed_VBD to_TO affect_VB the_DT polyadenylation_NN frequency_NN in_IN transient_JJ transfection_NN assays_NNS with_IN a_DT replication-defective_JJ virus_NN ._SENT SR_NN proteins_NNS may_MD also_RB modulate_VB polyadenylation_NN efficiency_NN ._SENT For_IN instance_NN ,_, SR_NN proteins_NNS SAP75_NP and_CC U2AF65_NP can_MD interact_VB with_IN the_DT poly(A)_JJ polymerase_NN ;_: however_RB ,_, this_DT interaction_NN has_VBZ been_VBN seen_VBN to_TO exert_VB a_DT negative_JJ effect_NN on_IN polyadenylation_NN efficiency_NN ._SENT Nevertheless_RB ,_, different_JJ SR_NN proteins_NNS may_MD have_VB a_DT positive_JJ effect_NN on_IN polyadenylation_NN ._SENT Besides_IN hnRNP_NN H_NN and_CC SR_NN proteins_NNS ,_, components_NNS of_IN the_DT U1_JJ snRNP_NN ,_, which_WDT also_RB binds_VBZ to_TO the_DT NRS_NN ,_, have_VBP been_VBN shown_VBN to_TO recruit_VB polyadenylation_NN factors_NNS ._SENT The_DT U1_JJ snRNP-associated_JJ protein_NN U1A_NP has_VBZ been_VBN found_VBN to_TO interact_VB with_IN the_DT cleavage-polyadenylation_NN specificity_NN factor_NN and_CC to_TO aid_VB in_IN its_PP$ recruitment_NN ._SENT In_IN addition_NN ,_, the_DT U1_JJ snRNP_NN 70,000-molecular-weight_JJ protein_NN has_VBZ been_VBN found_VBN to_TO bind_VB to_TO the_DT polyadenylation_NN polymerase_NN and_CC to_TO inhibit_VB polyadenylation_NN of_IN bovine_JJ papillomavirus_NN RNA_NP ._SENT In_IN that_DT case_NN ,_, however_RB ,_, the_DT U1_JJ snRNP_NN binding_VBG site_NN is_VBZ immediately_RB upstream_RB of_IN the_DT AAUAAA_NP polyadenylation_NN signal_NN ._SENT Thus_RB ,_, the_DT NRS_NN may_MD promote_VB polyadenylation_NN not_RB only_RB through_IN interactions_NNS with_IN hnRNP_NN H_NN and_CC SR_NN proteins_NNS but_CC also_RB through_IN binding_VBG of_IN U1_JJ snRNP_NN or_CC other_JJ factors_NNS ._SENT The_DT NRS_NN is_VBZ a_DT bipartite_JJ element_NN :_: the_DT function_NN of_IN the_DT 5_CD '_POS end_NN is_VBZ not_RB limited_VBN to_TO recruiting_VBG U1_JJ snRNP_NN to_TO the_DT 3_CD '_POS end_NN ._SENT |_SYM Our_NN experiments_NNS showed_VBD that_IN a_DT single_JJ point_NN mutation_NN in_IN the_DT NRS_NN can_MD cause_VB short-latency_NN lymphomas_NNS that_WDT are_VBP associated_VBN with_IN integrations_NNS into_IN the_DT oncogene_NN c-myb_NN ,_, similar_JJ to_TO the_DT previously_RB characterized_VBN lymphomas_NNS induced_VBN by_IN DeltaLR-9_NP ._SENT Thus_RB ,_, we_PP have_VBP observed_VBN that_IN mutations_NNS at_IN either_DT end_NN of_IN the_DT NRS_NN (_( the_DT 5_CD '_POS end_NN in_IN DeltaLR-9_NP and_CC the_DT 3_CD '_POS end_NN in_IN G919A_NP )_) can_MD increase_VB the_DT frequency_NN of_IN short-latency_NN lymphomas_NNS ._SENT This_DT confirms_VBZ the_DT original_JJ observation_NN that_IN both_DT 5_CD '_POS and_CC 3_CD '_'' NRS_NN regions_NNS are_VBP important_JJ for_IN the_DT function_NN of_IN the_DT NRS_NN ._SENT However_RB ,_, it_PP has_VBZ been_VBN proposed_VBN that_IN the_DT main_JJ function_NN of_IN the_DT 5_CD '_POS region_NN of_IN the_DT NRS_NN is_VBZ to_TO bind_VB SR_NN proteins_NNS in_IN order_NN to_TO recruit_VB U1_JJ snRNP_NN to_TO the_DT 3_CD '_POS region_NN of_IN the_DT NRS_NN ._SENT McNally_NP and_CC McNally_NP found_VBD that_IN U1_JJ snRNP_NN binding_VBG to_TO the_DT NRS_NN was_VBD greatly_RB reduced_VBN in_IN an_DT affinity_NN selection_NN assay_NN with_IN a_DT mutant_NN that_WDT was_VBD missing_VBG the_DT 5_CD '_POS region_NN of_IN the_DT NRS_NN containing_VBG the_DT SR_NN protein_NN binding_VBG sites_NNS ._SENT In_IN contrast_NN ,_, affinity_NN selection_NN experiments_NNS carried_VBD out_RP in_IN our_PP$ lab_NN demonstrated_VBD that_IN the_DT 3_CD '_POS region_NN of_IN the_DT NRS_JJ (_( nt_NN 903_CD to_TO 939_CD )_) was_VBD sufficient_JJ to_TO bind_VB U1_JJ snRNP_NN (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN addition_NN ,_, in_IN the_DT present_JJ study_NN the_DT DeltaLR-9_NP mutation_NN (_( nt_NN 735_CD to_TO 776_CD )_) did_VBD not_RB inhibit_VB U1_JJ snRNP_NN recruitment_NN to_TO the_DT full-length_JJ NRS_JJ construct_NN ._SENT Our_PP$ data_NNS indicate_VBP that_IN the_DT function_NN of_IN the_DT 5_CD '_POS region_NN of_IN the_DT NRS_NN is_VBZ not_RB limited_VBN to_TO recruiting_VBG U1_JJ snRNP_NN to_TO the_DT 3_CD '_POS end_NN since_IN the_DT mutation_NN in_IN DeltaLR-9_NP partially_RB inhibits_VBZ NRS_JJ function_NN (_( suppression_NN of_IN readthrough_NN and_CC splicing_VBG )_) but_CC the_DT DeltaLR-9_NP NRS_NP is_VBZ nevertheless_RB able_JJ to_TO recruit_VB U1_JJ snRNP_NN efficiently_RB in_IN vitro_NN ._SENT The_DT G919A_NP NRS_NN mutant_NN causes_VBZ a_DT high_JJ incidence_NN of_IN short-latency_NN lymphomas_NNS ._SENT |_SYM In_IN the_DT short-latency_NN lymphomas_NNS studied_VBD here_RB ,_, the_DT locations_NNS of_IN proviral_JJ integration_NN sites_NNS in_IN c-myb_NP intron_NP 1_CD were_VBD similar_JJ to_TO those_DT in_IN EU-8-induced_JJ tumors_NNS previously_RB observed_VBD ._SENT Since_IN most_JJS of_IN the_DT integrations_NNS that_WDT produced_VBD lymphomas_NNS clustered_VBN within_IN 900_CD nt_NNS upstream_RB of_IN the_DT start_NN of_IN exon_NN 2_CD ,_, it_PP is_VBZ possible_JJ that_IN the_DT processivity_NN of_IN the_DT transcribing_VBG polymerase_NN may_MD be_VB a_DT limiting_VBG factor_NN for_IN tumor_NN development_NN (_( reviewed_VBN in_IN reference_NN )_) ._SENT In_IN addition_NN ,_, all_RB of_IN the_DT selected_JJ integrations_NNS are_VBP downstream_JJ of_IN a_DT transcriptional_JJ pause_NN site_NN found_VBN in_IN intron_NP 1_CD of_IN c-myb_NP ,_, which_WDT has_VBZ been_VBN studied_VBN in_IN human_JJ and_CC murine_JJ c-myb_NN genes_NNS ._SENT Also_RB ,_, integration_NN into_IN c-myb_NP alone_RB may_MD be_VB sufficient_JJ to_TO cause_VB short-latency_NN lymphomas_NNS ,_, because_IN two_CD of_IN four_CD tumors_NNS examined_VBN by_IN inverse_JJ PCR_NP had_VBD no_DT other_JJ integrations_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT We_PP observed_VBD that_IN a_DT silent_JJ NRS_JJ point_NN mutation_NN (_( G919A_NP )_) caused_VBD short-latency_NN lymphomas_NNS effectively_RB ,_, showing_VBG that_IN a_DT defective_JJ NRS_NN and_CC not_RB a_DT truncated_JJ MA_NN protein_NN is_VBZ the_DT cause_NN of_IN the_DT high_JJ frequency_NN of_IN short-latency_NN tumor_NN induction_NN by_IN DeltaLR-9_NP ._SENT In_IN the_DT case_NN of_IN DeltaLR-9_NP ,_, increased_VBD readthrough_NN may_MD contribute_VB to_TO increased_VBN expression_NN of_IN truncated_JJ Myb_NP ,_, thus_RB explaining_VBG ,_, at_IN least_JJS partially_RB ,_, why_WRB DeltaLR-9_NP causes_VBZ a_DT higher_JJR level_NN of_IN short-latency_NN lymphomas_NNS than_IN LR-9_NP ._SENT Perhaps_RB the_DT NRS_JJ functions_NNS in_IN ALVs_NP to_TO limit_VB readthrough_JJ transcription_NN into_IN a_DT wide_JJ variety_NN of_IN downstream_JJ cellular_JJ genes_NNS ._SENT Interestingly_RB ,_, the_DT U916A_NP mutant_NN in_IN RSV_NP shows_VBZ RNA_NP readthrough_NP levels_NNS that_WDT are_VBP identical_JJ to_TO those_DT of_IN WT_NP RSV_NP ,_, while_IN readthrough_NN is_VBZ increased_VBN by_IN 50_CD %_NN with_IN the_DT RSV_NP G919A_NP mutant_JJ virus_NN ._SENT Thus_RB ,_, short-latency_NN tumor_NN induction_NN with_IN ALV_NP mutants_NNS G919A_NP and_CC DeltaLR-9_NP correlates_NNS with_IN increased_VBN readthrough_NN of_IN the_DT poly(A)_JJ site_NN ,_, as_RB determined_VBN in_IN RSV_NP for_IN the_DT mutants_NNS with_IN point_NN mutations_NNS ._SENT In_IN addition_NN ,_, once_RB readthrough_NN has_VBZ occurred_VBN ,_, splicing_VBG to_TO c-myb_NP is_VBZ most_RBS likely_JJ also_RB increased_VBN in_IN NRS_JJ mutants_NNS ,_, analogous_JJ to_TO the_DT increase_NN in_IN splicing_VBG to_TO src_NN in_IN RSV_NP ._SENT RSV_NP has_VBZ two_CD alternate_JJ 3_CD '_POS splice_NN sites_NNS (_( for_IN env_NP and_CC the_DT cell-derived_JJ src_NN )_) ._SENT O'Sullivan_NP et_FW al._FW found_VBN 